NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis.
about
Pharmacological treatments for non-alcohol related fatty liver disease (NAFLD): a network meta-analysisGlycosyltransferases and non-alcoholic fatty liver diseasePrevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in IranHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children.Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterolMechanism of the effect of glycosyltransferase GLT8D2 on fatty liver.Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewEpidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis.Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease.Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.Hispanic health in the USA: a scoping review of the literature.
P2860
Q24186865-57F7010C-9228-481A-8AE8-7C769293FB8DQ26764913-E76541E9-B038-43A2-BC6D-E29ED27CC165Q28079534-0031367A-81CE-420C-853E-CC81304A01F3Q30234574-03F63FD5-2A8A-4FAA-9665-F73F20FE7D7EQ30241387-FE820114-5F88-437C-A16C-8A13ED6EEFB2Q30241654-62FB3A3B-4059-4E7F-8F1E-38FC752CB253Q34501819-2EAA553F-3A48-4946-AAFD-9ED0DA65E588Q35588261-769F674A-9B7E-478C-A2C9-A7970004B244Q36369189-7E225F36-AF80-422C-8108-9E0F72D89330Q38607500-711E1F1C-F660-4EC5-9042-30AE66FC81DEQ38607766-3652940E-09D5-45AB-B91D-BDADC5E2599BQ38867031-4CC65094-59B0-4BFF-9206-5E3723FAB2D2Q45067817-FDED3C8F-DD8A-4839-9606-FB823AE86C6FQ46090216-768553CB-993D-4A2C-AA26-79E6C241412DQ48607503-988D81E4-1EB7-4462-94B3-3096CD893250Q49193626-E1311F82-ADC9-4C2D-927C-82C4F13D8025Q49954571-8E7C4EE2-EAEA-4147-97F6-8EB956E4CC32
P2860
NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@ast
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@en
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@nl
type
label
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@ast
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@en
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@nl
prefLabel
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@ast
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@en
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@nl
P2093
P2860
P356
P1476
NAFLD prevalence differs among ...... hnic Study of Atherosclerosis.
@en
P2093
Michael Wayne Fleischman
Temitope Foster
P2860
P304
P356
10.3748/WJG.V20.I17.4987
P407
P577
2014-05-01T00:00:00Z